Explore current events topics
Understanding current events in addiction and mental health
Addiction and mental health are not static fields. The drug supply changes, treatment access expands or contracts with policy decisions, research reshapes best practices, and national awareness campaigns bring attention to problems that often stay hidden.
Staying informed is not academic. What is in the drug supply right now, what help is legally available, and what warning signs matter most all change from year to year, and that information can protect lives.
This category covers the developments that matter most to individuals and families affected by addiction and mental health conditions, emerging substances and contamination in the illicit drug supply, national overdose and mental health data, awareness months and observances, seasonal challenges like holidays in recovery, and changes in policy, insurance, and treatment access.
Our goal is to translate news and data into practical guidance.
Emerging drug trends
The illicit drug supply has changed dramatically over the past decade, and the changes carry direct safety implications.
- Fentanyl. Illicitly manufactured fentanyl now drives the majority of overdose deaths in the United States. It is frequently pressed into counterfeit pills and mixed into other drugs, so people often do not know they are taking it.
- Polysubstance overdose. A growing share of overdose deaths involve more than one substance, most often fentanyl combined with stimulants like methamphetamine or cocaine.
- Adulterants like xylazine. Xylazine, an animal tranquilizer increasingly found mixed with fentanyl, does not respond to naloxone and causes severe wounds, complicating overdose response and treatment.
- Counterfeit pills. Pills sold as Adderall, Xanax, or oxycodone are frequently counterfeit and may contain fentanyl or methamphetamine. Any pill not dispensed by a pharmacy should be treated as untrusted.
- A hopeful shift. After years of increases, national overdose deaths have declined sharply, driven by expanded naloxone access, treatment availability, and shifts in the drug supply. Sustained progress depends on people continuing to get connected to care.
Why this matters for families
Parents, partners, and friends are usually the first to notice a problem, and what they know shapes how well they can help. Knowing that counterfeit pills now dominate the illicit market changes the conversation a parent has with a teenager.
Knowing naloxone is available over the counter means families can keep it on hand. And because overdose deaths spike around certain holidays, when recovery is hardest, current information helps families plan support for the moments that matter most.
Our track record of success
We are here to help individuals and families manage mental health conditions
Treatment Excellence
Success stories
“Red Ribbon Recovery Indiana gave me more than sobriety, it gave me a new perspective on life. The team helped me confront the trauma that fueled my drug addiction and rebuild trust with my family.”
Daniel R.
Completed outpatient program, 2025
“After years of battling opioid addiction, I finally found a place that understood both my physical and emotional pain. The combination of therapy and medical support made all the difference.”
Alyssa T.
Completed outpatient program, 2025
“I relapsed several times before finding Red Ribbon Recovery. They didn’t judge me, they adjusted my treatment plan and helped me find a strategy that worked. I’ve been clean for almost a year.”
Marcus P.
Completed outpatient program, 2025
“Before coming to Red Ribbon Recovery Indiana, I didn’t believe recovery was possible for me. I’d lost my job, my husband, and most of my confidence. The staff helped me rebuild my life from the inside out. I’m finally proud of the person I’m becoming.”
Jasmine L.
Completed outpatient program, 2025
Trends by the numbers
Understanding the current landscape of addiction and mental health in the United States
CDC 2026
CDC 2024
CDC 2024
FDA 2023
SAMHSA
SAMHSA 2025
Awareness observances we cover
- January. Dry January, a month-long alcohol-free challenge many people use to reassess their relationship with drinking.
- March. National Drug and Alcohol Facts Week, focused on giving young people accurate information about substance use.
- April. Alcohol Awareness Month, highlighting the risks of alcohol misuse and paths to treatment.
- May. Mental Health Awareness Month, the largest annual observance focused on mental health education and reducing stigma.
- June. PTSD Awareness Month, focused on trauma, its connection to substance use, and effective treatment.
- August. International Overdose Awareness Day (August 31), the world’s largest campaign to end overdose and remember those lost.
- September. National Recovery Month, celebrating people in recovery and the treatment and support services that make recovery possible.
- October. Talk About Your Medicines Month and Red Ribbon Week (October 23-31), the nation’s largest drug-use prevention campaign.
- December. National Impaired Driving Prevention Month, timed to the holiday season when alcohol-related crashes rise.
Policy and access developments
Changes in law and policy directly affect who can get help and how quickly. Recent years have brought meaningful expansions: over-the-counter naloxone, the nationwide 988 crisis line, broader telehealth access to addiction and mental health care, and loosened restrictions on medications for opioid use disorder.
This category tracks developments like these, along with insurance and parity enforcement, so readers understand what care they are entitled to and how to access it.
Evidence-based treatment options
Drug and alcohol detox
Drug and alcohol detox, also known as medical detox, is the first step in recovery. It provides medical supervision to manage withdrawal symptoms safely. This short-term process at an Indiana drug rehab center helps individuals stabilize physically and prepare for ongoing substance use disorder treatment.
Inpatient treatment
An inpatient program, also known as residential addiction treatment, is a highly structured, 24/7 program that offers intensive therapy, medical support, and continuous supervision. This level of care is ideal for individuals who need a stable and supportive environment to begin their recovery at our addiction treatment centers Indiana.
Partial hospitalization program
A partial hospitalization program treatment, also known as a day treatment program, is the highest level of outpatient care, with programming scheduled four to five days a week. Some people start rehab in our day treatment program while others transition after completing inpatient treatment.
Intensive outpatient program
Intensive outpatient treatment is available in person and virtually, meeting three to four days a week with a mix of group therapy and individual sessions. Specialized programs support diverse needs, including dedicated tracks for LGBTQ+ individuals, men, women, and more.
Standard outpatient treatment
Standard outpatient treatment is a flexible option for individuals with mild substance use disorders or those transitioning from higher levels of care. Treatment typically includes scheduled therapy sessions that address addiction triggers, coping strategies, and ongoing challenges in maintaining sobriety.
Dual diagnosis treatment
Dual diagnosis treatment addresses both substance use and mental health disorders, recognizing that treating only one can worsen the other. This program begins with an assessment for an accurate diagnosis, followed by an integrated approach combining therapy, medication management, and supportive care.
Telehealth mental health/virtual addiction treatment
Telehealth provides access to therapy, counseling, and medication management through secure video or phone sessions. This approach makes care more accessible for people who cannot attend in person, offering flexibility while still maintaining professional support for mental health and substance use disorders.
Addiction aftercare program
Long-term recovery often requires ongoing commitment and support. Continued engagement with counseling, support groups, healthy routines, and recovery-focused resources can help strengthen sobriety and promote lasting personal growth.
Outpatient detox program
Detox can be an important first step for individuals who are physically dependent on drugs or alcohol. When withdrawal symptoms are a concern, receiving appropriate medical support before beginning ongoing addiction treatment can help improve safety, comfort, and treatment outcomes.
Frequently asked questions
Where can I find addiction and mental health treatment in Indiana?
If you are seeking addiction treatment in Indiana, you will find a wide range of recovery centers located across the state, in major cities such as Indianapolis, Fort Wayne, Evansville, South Bend, Bloomington, Lafayette, Gary, Muncie, Terre Haute, Elkhart, Kokomo, Richmond, Noblesville, and Carmel.
Our facility is accessible for residents of Indiana and surrounding states. Conveniently located near Indiana University and major airports, our center is within driving distance of:
- Greenwood, Indiana
- Indianapolis, Indiana
- Fort Wayne, Indiana
- Evansville, Indiana
- South Bend, Indiana
- Bloomington, Indiana
- Carmel, Indiana
- Lafayette, Indiana
- Terre Haute, Indiana
- Kokomo, Indiana
- Fishers, Indiana
- Muncie, Indiana
- Elkhart, Indiana
- Anderson, Indiana
- Noblesville, Indiana
Our admissions coordinators are available to assist with travel arrangements and answer any questions about entering treatment. For ongoing recovery support, we also encourage participation in local and statewide community resources.
Why are overdose deaths declining?
After peaking above 110,000 annual deaths, national overdose deaths have fallen substantially. Public health experts point to several contributing factors: wider naloxone availability, including over-the-counter access, expanded treatment and medication for opioid use disorder, harm reduction outreach, and changes in the illicit drug supply. The decline is real progress, but overdose remains a leading cause of death for adults under 45, and the drop has not been even across all communities.
What is xylazine and why is it dangerous?
Xylazine is a veterinary sedative increasingly found mixed into illicit fentanyl. Because it is not an opioid, naloxone does not reverse its effects, which complicates overdose response. It also causes severe skin wounds with repeated use. If an overdose is suspected, naloxone should still be given, since fentanyl is almost always present, and emergency services should be called immediately.
Is naloxone available in Indiana?
Yes. Naloxone (Narcan) is available over the counter at pharmacies nationwide, and Indiana’s standing order and community distribution programs make it available at low or no cost through many local health departments and harm reduction organizations. Anyone who uses opioids, or who lives with someone who does, should keep naloxone on hand and know how to use it.
How do current events affect treatment access?
Policy changes shape what treatment looks like in practice. Telehealth expansion means virtual treatment is now a standard option for therapy, psychiatry, and addiction care. Parity enforcement affects what insurance must cover. Changes to medication rules affect how quickly people can start treatment for opioid use disorder. We cover these developments so readers know their options before they need them.
Are counterfeit pills really that common?
Yes. Law enforcement testing has found that a majority of counterfeit prescription pills seized contain fentanyl, often in potentially lethal doses. Counterfeits are made to look identical to real Adderall, Xanax, Percocet, and oxycodone. The practical rule is simple: any pill that did not come directly from a licensed pharmacy should be assumed dangerous.
Sources
- Centers for Disease Control and Prevention. (2026). Provisional Drug Overdose Death Counts.
- Substance Abuse and Mental Health Services Administration. (July 28, 2025). Results from the 2024 National Survey on Drug Use and Health
- U.S. Food and Drug Administration. (March 29, 2023). FDA Approves First Over-the-Counter Naloxone Nasal Spray
- Drug Enforcement Administration. (n.d.). Counterfeit pill fact sheet and One Pill Can Kill campaign
- Centers for Disease Control and Prevention. (n.d.). What You Should Know About Xylazine
- National Institute on Drug Abuse. (August 21, 2024). Drug Overdose Deaths: Facts and Figures
About the content
Written by: Carli Simmonds. Carli Simmonds holds a Master of Arts in Community Health Psychology from Northeastern University. From a young age, she witnessed the challenges her community faced with substance abuse, addiction, and mental health challenges, inspiring her dedication to the field.
Medically reviewed by: Jodi Tarantino, LICSW. Jodi Tarantino is an experienced, licensed Independent Clinical Social Worker (LICSW) and Program Director with over 20 years of experience in Behavioral Healthcare. Also reviewed by the RRR Editorial team.
Red Ribbon Recovery is committed to delivering transparent, up-to-date, and medically accurate information. All content is carefully written and reviewed by experienced professionals to ensure clarity and reliability. During the editorial and medical review process, our team fact-checks information using reputable sources. Our goal is to create content that is informative, easy to understand and helpful to our visitors.